Abstract
Pancreatic ductal adenocarcinoma (PDAC), the most prevalent form of pancreatic cancer, still has a dismal prognosis despite of improvements in treatment options. Response and survival rates vary highly between patients, and good predictors for survival are lacking. In general, treatment decisions are solely based on the condition of the patient and not on prognostic or predictive
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 17 Apr 2026 |
| Print ISBNs | 9789493483385 |
| Publication status | Published - 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 7 Affordable and Clean Energy
Fingerprint
Dive into the research topics of 'Towards personalized treatment for pancreatic cancer patients using genomics and transcriptomics - the PEGASUS project'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver